MIRAPEX
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Quick answers
Is there a shortage of MIRAPEX in Canada?
No. There is no current shortage of MIRAPEX 0.125MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TEVA-PRAMIPEXOLE
TEVA CANADA LIMITED
DOM-PRAMIPEXOLE
DOMINION PHARMACAL
AURO-PRAMIPEXOLE
AURO PHARMA INC
NTP-PRAMIPEXOLE
NT PHARMA CANADA LTD
SANDOZ PRAMIPEXOLE
SANDOZ CANADA INCORPORATED
APO-PRAMIPEXOLE
APOTEX INC
DIN
02297256
Strength
0.125MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE
See all PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02242119
250MG · DIN 02273322
20MCG · DIN 02247686
DIN 02419106
DIN 02231675
0.4MG · DIN 02270102
40MG · DIN 02415682
20MG · DIN 02415666
30MG · DIN 02415674
DIN 02459760
DIN 02459752
DIN 02441888